Showing 1991-2000 of 8649 results for "".
- Oculis to Present a Late-Breaking Abstract at Euretina on Phase 3 Stage 1 DIAMOND Trial Results for Diabetic Macular Edemahttps://modernod.com/news/oculis-to-present-a-late-breaking-abstract-at-euretina-on-phase-3-stage-1-diamond-trial-results-for-diabetic-macular-edema/2481867/Oculis announced that the positive readout from Stage 1 of its phase 3 DIAMOND trial of OCS-01 in patients with diabetic macular edema (DME) will be presented as a late-breaking abstract at the 23rd Euretina Congress, taking place October 5-8, 2023 in Amsterdam, the Netherlands.
- Thea Pharma Announces the US Launch of Glaucoma Drug Iyuzehhttps://modernod.com/news/thea-pharma-announces-the-us-launch-of-glaucoma-drug-iyuzeh/2481850/Thea Pharma announced the launch and availability of Iyuzeh (latanoprost ophthalmic solution) 0.005% in the US market. Iyuzeh, which received FDA approval in December 2022, is the first and only preservative-free latanoprost for patients with primary open-angle glaucoma (
- NovaBay Pharmaceuticals’ Avenova Allograft is Launched in the United Stateshttps://modernod.com/news/novabay-pharmaceuticals-avenova-allograft-is-launched-in-the-united-states/2481830/NovaBay Pharmaceuticals announced the launch of the Avenova Allograft in the United States through its physician-dispensed channel. The company’s prescription optic allograft, which is intended for use as a protective covering during the repair of ocular surfaces, is manufactured using BioS
- Ace Vision Group to Present Nine New Sets of Scientific Data Focused on Laser Scleral Microporation at the ESCRS Annual Meetinghttps://modernod.com/news/ace-vision-group-to-present-nine-new-sets-of-scientific-data-focused-on-laser-scleral-microporation-at-the-escrs-annual-meeting/2481820/Ace Vision Group (AVG) announced it will present nine sets of research on the effectiveness of Laser Scleral Microporation (LSM) at the annual congress of the European Society of Cataract and Refractive Surgeons (ESCRS). LSM is an ultra-minimally invasive procedure with a nov
- Amgen and Horizon Therapeutics Resolve FTC Lawsuit Clearing Path to Acquisitionhttps://modernod.com/news/amgen-and-horizon-therapeutics-resolve-ftc-lawsuitclearing-path-to-acquisition/2481806/Amgen and Horizon Therapeutics announced the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. The order clears a path forward to closing its planned $27.8-billion takeout 
- Johnson & Johnson Vision Announces Launch of Elita Platform to Correct Myopia with New SILK Procedurehttps://modernod.com/news/johnson-johnson-vision-announces-launch-of-elita-platform-to-correct-myopia-with-new-silk-procedure/2481802/Johnson & Johnson Vision will launch the new Elita Platform at European Society of Cataract and Refractive Surgeons (ESCRS) Congress, September 8-12, 2023, in Vienna, Austria. The Elita Platform enables surgeons to perform refractive correction on patients w
- Laboratoires Théa Acquires ProQR Therapeutics' Sepofarsen and Ultevursenhttps://modernod.com/news/laboratoires-thea-acquires-proqr-therapeutics-sepofarsen-and-ultevursen/2481765/ProQR Therapeutics and Laboratoires Théa announced an agreement in which ProQR will divest its late stage ophthalmic assets, sepofarsen and ultevursen, to Théa. Under the terms of the agreement, ProQR will receive an initial payment of €12.5 million ($13.7 m
- Mount Sinai Launches Center for Ophthalmic Artificial Intelligence and Human Healthhttps://modernod.com/news/mount-sinai-launches-center-for-ophthalmic-artificial-intelligence-and-human-health/2481706/The Icahn School of Medicine at Mount Sinai has launched the Center for Ophthalmic Artificial Intelligence and Human Health, the first-of-its-kind in New York and one of the first in the United States. The Center is dedicated to advancing artificial intelligence (AI) in the field of ophthalm
- Bausch + Lomb Launches PreserVision AREDS 2 Formula Soft Gels Plus CoQ10 in the United Stateshttps://modernod.com/news/bausch-lomb-launches-preservision-areds-2-formula-soft-gels-plus-coq10-in-the-united-states/2481667/Bausch + Lomb announced the US launch of PreserVision AREDS 2 Formula soft gels plus coenzyme Q10 (CoQ10). Developed as a two-in-one option, Bausch + Lomb says PreserVision AREDS 2 Formula eye vitamins plus CoQ10 is the only eye vitamin that combines the exact nutrient formula
- AOS Launches Remote Visual Acuity System Platformhttps://modernod.com/news/aos-launches-remote-visual-acuity-system-platform/2481652/AOS (Advanced Ophthalmic Systems) announced the launch of a new remote visual acuity software platform. The AOS VA software is a synchronous test that requires internet connection and can be used on multiple device types. Using a combination of semi-automated test algorithms a